Further examination of the effects of these compounds on FSHD patient–derived muscle cells led to the discovery that p38 inhibition causes a reduction in DUX4 mRNA that in turn results in decreased mRNA levels of several DUX4 target genes (97, 98). The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.